Prevention of heterotopic ossification in cases of hypertrophic osteoarthritis submitted to total hip arthroplasty. Etidronate or indomethacin?

Journal of Musculoskeletal Neuronal Interactions

Volumn 10, Issue 2, 2010, Pages 159-165

  Vasileiadis, G I ^a   Sakellariou, V I ^a   Kelekis, A ^a   Galanos, A ^a   Soucacos, P N ^a   Papagelopoulos, P J ^a   Babis, G C ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Arthroplasty; Etidronate; Heterotopic; Hip; Hypertrophic; Indomethacin; Ossification; Osteoarthritis

Indexed keywords

ETIDRONIC ACID; INDOMETACIN;

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; FOLLOW UP; HARRIS HIP SCORE; HEART RATE; HETEROTOPIC OSSIFICATION; HIP RADIOGRAPHY; HUMAN; HYPERTROPHIC OSTEOARTHROPATHY; MAJOR CLINICAL STUDY; MALE; NAUSEA; NIGHTMARE; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STOMACH PAIN; TOTAL HIP PROSTHESIS; TREATMENT DURATION; TREATMENT PLANNING;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; ETIDRONIC ACID; FEMALE; HUMANS; INDOMETHACIN; MALE; MIDDLE AGED; OSSIFICATION, HETEROTOPIC; OSTEOARTHRITIS, HIP; TREATMENT OUTCOME;

EID: 77954828668     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Brooker AF, Bowerman JW, Robinson RA, Riley LH Jr. Ectopic ossification following total hip replacement. Incidence and a method of classification. J Bone Joint Surg Am 1973;55(8):1629-32.
2. Hastings H II, Graham TJ. The classification and treatment of heterotopic ossification about the elbow and forearm. Hand Clinics August 1994;10(3).
3. Fransen M, Neal B. Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty. Cochrane Database Syst Rev 2004; 3:CD001160.
4. Fransen M, Anderson C, Douglas J, MacMahon S, Neal B, Norton R, Woodward M, Cameron ID, Crawford R, Lo SK, Tregonning G, Windolf M; HIPAID Collaborative Group. Safety and efficacy of routine postoperative ibuprofen for pain and disability related to ectopic bone formation after hip replacement surgery (HIPAID): randomised controlled trial. BMJ 2006;333:519.
5. Toom A, Haviko T, Rips L. Heterotopic ossification after total hip arthroplasty. Int Orthop 2001;24(6):323-6.
6. Romanò CL, Duci D, Romanò D, Mazza M, Meani E. Celecoxib versus Indomethacin in the prevention of Heterotopic Ossification after Total Hip Arthroplasty. The Journal of Arthroplasty 2004;19(1).
7. Higo T, Mawatari M, Shigematsu M, Hotokebuchi T. The incidence of Heterotopic Ossification after Cementless Total Hip Arthroplasty. The Journal of Arthroplasty 2006;21(6).
8. Iorio R, Healy W. Heterotopic ossification after hip and knee arthroplasty: risk factors, prevention, and treatment, J Am Acad Orthop Surg 2002;10:409.
9. Leif Ahrengart Periarticular Heterotopic Ossification after Total Hip Arthroplasty. Risk factors and consequences. Clinical Orthopaedics and Related Research Feb 1991;263:49-58.
10. Leif Ahrengart, Urban Lindgren Functional significance of heterotopic bone formation after total hip arthroplasty. The Journal of Arthroplasty 1989;4(2):125-131.
11. Riegler HF, Harris CM. Heterotopic bone formation after total hip arthroplasty. Clin Orthop Relat Res 1976;117:209.
12. McCluer S. Heterotopic ossification in Spinal Cord Injury. Arkansas Spinal Cord Commission, 1990.
13. Naraghi FF, DeCoster TA, Moneim MS, Miller RA, Rivero D. Heterotopic Ossification (Review). Orthopaedics 1996;19(2).
14. Speed J Heterotopic Ossification. eMedicine Journal, June 17 2001; 2(6)
15. Hedley AK, Mead LP, Hendren DH: The prevention of heterotopic bone formation following total hip arthroplasty using 600 rad in a single dose. J Arthroplasty 1989;4:319.
16. Kennedy WF, Gruen TA, Chessin H, et al: Radiation therapy to prevent heterotopic ossification after cementless total hip arthroplasty. Clin Orthop Relat Res 1991; 262:185.
17. Lo TC. Radiation therapy for heterotopic ossification. Semin Radiat Oncol 1999;9:163-70.
18. McAuliffe JA, Wolfson AH. Early excision of heterotopic ossification about the elbow followed by radiation therapy. J Bone Joint Surg Am 1997;79:749-55.
19. Pellegrini VD Jr, Gregoritch SJ. Preoperative irradiation for prevention of heterotopic ossification following total hip arthroplasty. J Bone Joint Surg Am 1996;78:870-81.
20. Cella JP, Salvati EA, Sculco TP. Indomethacin for the prevention of heterotopic ossification following total hip arthroplasty: effectiveness, contraindications and adverse effects. J Arthroplasty 1988;3:229-34.
21. Kjaersgaard-Andersen P, Ritter MA. Short-term treatment with nonsteroidal antiinflammatory medication to prevent heterotopic bone formation after total hip arthroplasty. Clin Orthop 1992;279:157-62.
22. Knelles D, Barthel T, Karer A, et al. Prevention of heterotopic ossification after total hip replacement: a prospective, randomized study using acetyl salicylic acid, indomethacin and fractional or single dose irradiation. J Bone Joint Surg Br 1997;79:596-602.
23. Kjaersgaard-Andersen P. and Ritter MA (Current concepts review) Prevention of formation of heterotopic bone after Total Hip Arthroplasty. The Journal of Bone and Joint Surgery 1991;73-A, No 6.
24. Thomas B, Baumann B, Noth U, Eulert J. Prophylaxis of heterotopic ossification after total hip arthroplasty. A prospective randomized study comparing indomethacin and meloxicam. Acta Orthop Scand 2002;73(6):611-4.
25. Keller JC, Trancik TM, Young FA, St Mary E. Effects of indomethacin on bone ingrowth. J Orthop Res 1989;7:28-34.
26. Trancik T, Mills W, Vinson N. The effect of indomethacin, aspirin, and ibuprofen on bone ingrowth into a porous-coated implant. Clin Orthop Relat Res 1989; 249:113-21.
27. Padgett DE, Holley KG, Cummings M, Rosenberg AG, Sumner DR, Conterato D, Galante JO. The efficacy of 500 cGy Radiation in the prevention of Heterotopic Ossification after Total Hip Arthroplasty: A prospective, randomized, pilot study. The Journal of Arthroplasty 2003;18(6).
28. Singer BR. Heterotopic ossification. Br J Hosp Med. 1993;49:247-255.
29. Thomas BJ, Amstutz HC. Prevention of heterotopic bone formation: clinical experience with diphosphonates. Hip. 1987:59-69.
30. Thomas BJ, Amstutz HC. Results of the administration of diphosphonate for the prevention of heterotopic ossification after total hip arthroplasty. J Bone Joint Surg Am 1985;67(3):400-3.
31. Yutani Y, Ohashi H, Nishimura N, Yamano Y. Clinical effect of etidronate disodium (EHDP) on heterotopic ossification following total hip arthroplasty. Osaka City Med J 1995;41(2):63-73.
32. Douglas E Garland, Betzabe Alday, Kenneth G Venos, Jean C Vogt. Diphosphonate treatment for heterotopic ossification in spinal cord injury patients. Clinical orthopaedics and related research 1983;176:197-200.
33. Grohs JG, Schmidt M, Wanivenhaus A Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up. Acta Orthop 2007;78(1):95-8.
34. Sneath RJS, Bindi FD, Davies J, Parnell EJ. The effect of pulsed irrigation on the incidence of heterotopic ossification after total hip arthroplasty. The Journal of Arthroplasty 2001;16(5):547-51.
35. Garland DE. A clinical perspective on common forms of acquired heterotopic ossification. Clin Orthop 1991;263:13-29.
36. Helms CA. "Skeletal don't touch" lesions. In: Brant WE, Helms CA; eds. Fundamentals of Diagnostic Radiology. Baltimore, MD: Williams & Wilkins; 1994:963-75.
37. Thomas BJ. Heterotopic bone formation after total hip arthroplasty. Orthop Clin North Am 1992;23:347-58.
38. Garland DE, Blum CE, Waters RL. Periarticular heterotopic ossification in head-injured adults: incidence and location. J Bone Joint Surg Am 1980;62:1143-6.
39. Roberts JB, Pankratz DG. The surgical treatment of heterotopic ossification at the elbow following long-term coma. J Bone Joint Surg Am 1979;61:760-3.
40. Freed JH, Hahn H, Menter R, Dillon T. The use of threephase bone scan in the early diagnosis of heterotopic ossification (HO) and in the evaluation of Didronel therapy. Paraplegia 1982;20:208-16.
41. Garland DE, Orwin JF. Resection of heterotopic ossification in patients with spinal cord injuries. Clin Orthop 1989;242:169-76.
42. Neal B. Effects of heterotopic bone formation on outcome after hip arthroplasty. (Review article) ANZ J Surg 2003; 73:422-6.
43. Sawyer JR, Myers MA, Rosier RN, Puzas JE. Heterotopic ossification: clinical and cellular aspects. Calcif Tissue Int 1991;49:208-15.
44. Schmidt J, Hackenbroch MH. A new classification for heterotopic ossification in total hip arthroplasty considering the surgical approach. Arch Orthop Trauma Surg 1996;115:339-43.
45. Elmsted E, Lindholm TS, Nilsson OS, Tornkvist H. Effect of ibuprofen on heterotopic ossification after hip replacement. Acta Orthop Scand 1985;56:25-7.
46. Freiberg AA, Cantor R, Freiberg RA. The use of aspirin to prevent heterotopic ossification after total hip arthroplasty. Clin Orthop 1991;267:93-6.
47. Neal BC, Rodgers A, Clark T, et al. A systematic survey of 13 randomized trial of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery. Acta Orthop Scand 2000;71:122-8.
48. Coventry MB, Scanlon PW. The use of radiation to discourage ectopic bone: a nine-year study in surgery about the hip. J Bone Joint Surg Am 1981;63:201-8.
49. rd Disodium etidronate in the prevention of postoperative recurrence of heterotopic ossification in spinal-cord injury patients J Bone Joint Surg Am 1976;58(5):683-8.
50. Ono K, Takaoka K, Kaneda K, Takahashi H, Otani K, Yoshikawa S, Kurokawa T, Nakagawa M, Shingu H. A double-blind study of EHDP on heterotopic ossification after spinal cord injury using placebo. Rinsho Hyoka 1988;16:581-615.
51. Orzel JA, Rudd TG. Heterotopic bone formation: clinical, laboratory and imaging correlation. J Nucl Med 1985;26:125-32.
52. Tsailas PG, Babis GC, Nikolopoulos K, Soucacos PN, Korres DS. The effectiveness of two COX-2 inhibitors in the prophylaxis against heterotopic new bone formation: an experimental study in rabbits. J Surg Res 2009;151(1):108-14.
53. Xue D, Zheng Q, Li H, Qian S, Zhang B, Pan Z. Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials. Int Orthop 2009 Oct 15. [Epub ahead of print].
54. Wurnig C, Schwameis E, Bitzan P, Kainberger F. Six-year results of a cementless stem with prophylaxis against heterotopic bone. Clin Orthop Relat Res 1999;361:150-8.
55. Strampel W, Emkey R, Civitelli R. Safety considerations with bisphosphonates for the treatment of osteoporosis Drug Saf 2007;30(9):755-63.